Les pneumopathies aigues du sujet age

SCOPUS: cp.jinfo:eu-repo/semantics/publishe

Dyspnoea, wheezing and respiratory insufficiency in pregnancy: Was it bronchial or cardiac astha?

SCOPUS: ed.jinfo:eu-repo/semantics/publishe

Chest physical examination: A new series of review papers

SCOPUS: ed.jinfo:eu-repo/semantics/publishe

The birth and development of the forced expiratory manoeuvre: A tribute to Robert Tiffeneau (1910-1961)

SCOPUS: re.jinfo:eu-repo/semantics/publishe

Que penser des corticoïdes en aérosol doseur ?

SCOPUS: ar.jinfo:eu-repo/semantics/publishe

Corticoïdes et bronchopneumopathies chroniques obstructives

SCOPUS: re.jinfo:eu-repo/semantics/publishe

Mechanical assistance in chronic respiratory insufficiency due to neuromuscular disease

It is now quite clear that patients with chronic respiratory failure due to neuromuscular disorders may be helped by night-time ventilation at home, or for some of them by diaphragm pacing. Their quality of life will be markedly improved as soon as the chronic hypercapnia disappears, although the mechanism for this disappearance remains incompletely understood. However, we have to face many ethical as well as practical problems to ensure these patients and their families a safe transition from the hospital to home care, requiring concerted interdisciplinary efforts.SCOPUS: ar.jinfo:eu-repo/semantics/publishe

Inhalation therapy: A historical perspective

SCOPUS: cp.jinfo:eu-repo/semantics/publishe

LES BRONCHODILATATEURS ENDOBRONCHIQUES

There are two families of inhaled bronchodilators: β-2-mimetics and vagolytics. They are equally effective in patients with chronic obstructive pulmonary disease (COPD), whereas β-mimetics are usually superior in asthmatics. The clinical benefits linked to long acting β-mimetics like salmeterol are already established in asthmatics. Metered dose aerosols remain the most widely used type of inhaler, eventually connected to a spacer, together with powder inhalers. Usual bronchodilators are now prescribed on demand rather than on a regular basis. There is no proof that β-mimetics are causally related to asthma deaths. Inhaled corticosteroids, which have no acute bronchospasmolytic properties, are the first-choice chronic drug treatment of moderate to severe asthma; they are currently being evaluated in COPD.SCOPUS: sh.jinfo:eu-repo/semantics/publishe

Asthme et BPCO: Diagnostic differentiel

SCOPUS: ar.jinfo:eu-repo/semantics/publishe